The 3000 Rice Genomes Project will use DNANexus' platform in effort to improve nutrition, climate tolerance, and disease resistance in rice.
The partners received £30,000 (about $46,000) in funding from the BBSRC to support their metabolomics data-sharing and analyses activities.
The project seeks to develop standardized guidelines and tools to map terms across ontologies and help simplify data search and integration.
Cancer-ID is a newly created consortium tasked with validating blood-based biomarkers, such as CTC, cfDNA, and miRNA to bring liquid biopsies into the clinic.
The group has developed tables that match genotype, phenotype, and clinical recommendations to help inform therapy choices at the point of care.
Cancer Research UK and the Medical Research Council are providing £5 million to establish the S-CORT Consortium to investigate bowel cancer biology.
The partners will collaborate on pediatric oncology research, with a goal of earning an NCI designation of Comprehensive Cancer Center.
Thirteen institutions and life sciences companies have teamed up to launch the free repository that will offer access to allele frequency information from genomes and exomes.
The Australian bioinformatics firm will contribute to developing international standards for integrated genomic and clinical data aggregation and sharing.
The National Access Project, led by the Personalized Medicine Initiative and Contextual Genomics, aims to provide tumor profiling for 2,000 Canadians.
The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.
Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.
Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.
In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.